BEHAVIORAL AND CARDIOVASCULAR EFFECTS OF DISRUPTING THE ANGIOTENSIN-II TYPE-2 RECEPTOR GENE IN MICE

被引:649
作者
HEIN, L
BARSH, GS
PRATT, RE
DZAU, VJ
KOBILKA, BK
机构
[1] STANFORD UNIV, FALK CARDIOVASC RES CTR, STANFORD, CA 94305 USA
[2] STANFORD UNIV, DEPT MED, STANFORD, CA 94305 USA
[3] STANFORD UNIV, DEPT GENET, STANFORD, CA 94305 USA
[4] STANFORD UNIV, DEPT PEDIAT, STANFORD, CA 94305 USA
[5] STANFORD UNIV, HOWARD HUGHES MED INST, STANFORD, CA 94305 USA
关键词
D O I
10.1038/377744a0
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
ANGIOTENSIN II, a potent regulator of blood pressure and of water and electrolyte balance, binds to two different G-protein-coupled receptors. The type-1 receptor (AT(1)) mediates the vasopressive and aldosterone-secreting effects of angiotensin II, but the function of the type-2 receptor (AT(2); refs 1, 2) is unknown, although it is expressed in both adult(3) and embryonic(4) life. To address this question, we have generated mice lacking the gene encoding the AT(2) receptor. Mutant mice develop normally, but have an impaired drinking response to water deprivatian as well as a reduction in spontaneous movements. Their baseline blood pressure is normal, but they show an increased vasopressor response to injection of angiotensin II. Thus, although the AT(2) receptor is not required for embryonic development, it plays a role in the central nervous system and cardiovascular functions that are mediated by the renin-angiotensin system.
引用
收藏
页码:744 / 747
页数:4
相关论文
共 30 条
[1]   ASSIGNMENT OF THE HUMAN ANGIOTENSIN-II TYPE-2 RECEPTOR GENE (AGTR2) TO CHROMOSOME XP22-Q23 BY FLUORESCENCE IN-SITU HYBRIDIZATION [J].
CHAASSAGNE, C ;
BEATTY, BG ;
MELOCHE, S .
GENOMICS, 1995, 25 (02) :601-603
[2]   THE EFFECT OF THE PUTATIVE AT(2) AGONIST, P-AMINOPHENYLALANINE(6) ANGIOTENSIN-II, ON THIRST AND SODIUM APPETITE IN RATS [J].
COONEY, AS ;
FITZSIMONS, JT .
EXPERIMENTAL PHYSIOLOGY, 1993, 78 (06) :767-774
[3]   DRINKING INDUCED BY SUBCUTANEOUS INJECTION OF ANGIOTENSIN-II IN THE RAT IS BLOCKED BY THE SELECTIVE AT(1) RECEPTOR ANTAGONIST DUP-753 BUT NOT BY THE SELECTIVE AT(2) RECEPTOR ANTAGONIST WL-19 [J].
DOURISH, CT ;
DUGGAN, JA ;
BANKS, RJA .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1992, 211 (01) :113-116
[4]   ANGIOTENSIN-II BINDING-SITES IN THE RAT FETUS - CHARACTERIZATION OF RECEPTOR SUBTYPES AND INTERACTION WITH GUANYL NUCLEOTIDES [J].
FEUILLAN, PP ;
MILLAN, MA ;
AGUILERA, G .
REGULATORY PEPTIDES, 1993, 44 (02) :159-169
[5]  
GEORGIEV V, 1991, METHOD FIND EXP CLIN, V13, P5
[6]  
GEORGIEV V, 1990, POL J PHARMACOL PHAR, V42, P553
[7]   EXPRESSION OF AT2-RECEPTORS IN THE DEVELOPING RAT FETUS [J].
GRADY, EF ;
SECHI, LA ;
GRIFFIN, CA ;
SCHAMBELAN, M ;
KALINYAK, JE .
JOURNAL OF CLINICAL INVESTIGATION, 1991, 88 (03) :921-933
[8]   EXPRESSION OF AT2 RECEPTORS IN RAT FETAL SUBDERMAL CELLS [J].
GRADY, EF ;
KALINYAK, JE .
REGULATORY PEPTIDES, 1993, 44 (02) :171-180
[9]   THE ROLE OF ANGIOTENSIN, AT1-RECEPTOR AND AT2-RECEPTOR IN THE PRESSOR, DRINKING AND VASOPRESSIN RESPONSES TO CENTRAL ANGIOTENSIN [J].
HOGARTY, DC ;
SPEAKMAN, EA ;
PUIG, V ;
PHILLIPS, MI .
BRAIN RESEARCH, 1992, 586 (02) :289-294
[10]   EFFECTS OF ANGIOTENSIN-II ON [H-3] NORADRENALINE RELEASE AND PHOSPHATIDYLINOSITOL HYDROLYSIS IN THE PARIETAL CORTEX AND LOCUS-COERULEUS OF THE RAT [J].
HUANG, Y ;
ROGERS, J ;
HENDERSON, G .
JOURNAL OF NEUROCHEMISTRY, 1987, 49 (05) :1541-1549